K-HEALTHinAIR

Knowledge for improving indoor AIR quality and HEALTH

Programme: Horizon Europe Grant Agreement No. 101057693
Duration: 01/09/2022 – 31/08/2026

Scope and objectives

K-HEALTHinAIR aims to provide a scientific-based assessment of the indoor air quality (IAQ) effects on health, based on the results of the clinical studies with 350 high-risk outpatients and an extensive monitoring of chemical and biological indoor air pollutants. For this purpose, several very representative indoor locations have been selected. To identify the determinants, a deep research study on sources, interactions and main correlations with health problems will be conducted. As a result, the project will deliver affordable measures to monitor and improve IAQ and guidelines to support real interventions.

K-HEALTHinAIR seeks to assess indoor air quality in 9 different representative scenarios at a European level based on a monitoring campaign of physical, chemical and biological parameters. The study will be carried out in 5 different pilots distributed throughout Europe: Barcelona, Rotterdam, Baden – Württemberg, Poland/Austria and Norway.

K-HEALTHinAIR main goals can be summarized as follows:
• Carry out a full characterization of indoor air quality in the selected scenarios
• Evaluate the information collected and identify the determinants of people’s health in each of the scenarios
• Research the sources of the main determinants for each scenario and propose solutions to improve the healthiness of the environments
• Improve user-level monitoring solutions, make them more friendly and develop new applications basing on the information collected
• Identify relevant stakeholders in Europe and beyond and select the most suitable means of communication, dissemination and engagement for each mapped group
• Address the sustainability of the project’ results to assure the continuity and scale up of its long-term effects.

ECHAlliance role

In K-HEALTHinAIR, ECHAlliance will lead the work strand related to the project’s communication, dissemination and exploitation of the results. As such, ECHAlliance will design the strategy and actions for raising awareness on the K-HEALTHinAIR’ achievements with a view to achieve their sustainability beyond the project’s funding period. To foster the acceptance of innovation, greater effort will be devoted to the translation and communication of project’s results and outputs making them accessible and understandable by the society at large. Within the K-HEALTHinAIR project’s management team, ECHAlliance will cover the role of the Dissemination and Communication Manager.

Consortium

The Europe-wide consortium includes 5 research & technology organisations (CARTIF acting also as coordinator, CSIC, CIEMAT, IDIBAPS & NOFER Institute), 2 hospitals (Clinic Hospital of Barcelona and Erasmus MC), 4 universities (Escola Nacional de Saúde Pública, Universidade Nova de Lisboa, Warsaw University of Technology, Medizinische Universität Wien & University of Agder), 2 industries (MANN+HUMMEL & Atos IT Solutions and Services), 2 SMEs (INBIOT & KVELOCE) and a digital health connector (ECHAlliance).